Literature DB >> 31262389

Viral and Bacterial Etiology of Acute Febrile Respiratory Syndrome among Patients in Qinghai, China.

Gao Shan Liu1, Hong Li2, Sheng Cang Zhao2, Rou Jian Lu1, Pei Hua Niu1, Wen Jie Tan1.   

Abstract

OBJECTIVE: This study was conducted to investigate the viral and bacterial etiology and epidemiology of patients with acute febrile respiratory syndrome (AFRS) in Qinghai using a commercial routine multiplex-ligation-nucleic acid amplification test (NAT)-based assay.
METHODS: A total of 445 nasopharyngeal swabs specimens from patients with AFRS were analyzed using the RespiFinderSmart22kit (PathoFinder BV, Netherlands) and the LightCycler 480 real-time PCR system.
RESULTS: Among the 225 (225/445, 51%) positive specimens, 329 positive pathogens were detected, including 298 (90.58%) viruses and 31 (9%) bacteria. The most commonly detected pathogens were influenza virus (IFV; 37.39%; 123/329), adenovirus (AdV; 17.02%; 56/329), human coronaviruses (HCoVs; 10.94%; 36/329), rhinovirus/enterovirus (RV/EV; 10.03%; 33/329), parainfluenza viruses (PIVs; 8.51%; 28/329), and Mycoplasma pneumoniae (M. pneu; 8.51%; 28/329), respectively. Among the co-infected cases (17.53%; 78/445), IFV/AdV and IFV/M. pneu were the most common co-infections. Most of the respiratory viruses were detected in summer and fall.
CONCLUSION: In our study, IFV-A was the most common respiratory pathogen among 22 detected pathogens, followed by AdV, HCoV, RV/EV, PIV, and M. pneu. Bacteria appeared less frequently than viruses, and co-infection was the most common phenomenon among viral pathogens. Pathogens were distributed among different age groups and respiratory viruses were generally active in July, September, and November. Enhanced surveillance and early detection can be useful in the diagnosis, treatment, and prevention of AFRS, as well as for guiding the development of appropriate public health strategies.
Copyright © 2019 The Editorial Board of Biomedical and Environmental Sciences. Published by China CDC. All rights reserved.

Entities:  

Keywords:  Acute febrile respiratory syndrome; Prevalence; Seasonal distribution; Viral and bacterial etiology

Mesh:

Year:  2019        PMID: 31262389      PMCID: PMC7135780          DOI: 10.3967/bes2019.058

Source DB:  PubMed          Journal:  Biomed Environ Sci        ISSN: 0895-3988            Impact factor:   3.118


  33 in total

1.  Screening of respiratory pathogens by Respiratory Multi Well System (MWS) r-gene™ assay in hospitalized patients.

Authors:  Pierpaolo Paba; Francesca Farchi; Erika Mortati; Massimo Ciccozzi; Micol Piperno; Carlo Federico Perno; Marco Ciotti
Journal:  New Microbiol       Date:  2014-04-01       Impact factor: 2.479

2.  [Prevalence and seasonal distribution of respiratory viruses in patients with acute respiratory tract infections, 2002-2014].

Authors:  Candan Çiçek; Ayşe Arslan; Haydar Soydaner Karakuş; Mehmet Yalaz; Eylem Ulaş Saz; Hüsnü Pullukçu; Gürsel Çok
Journal:  Mikrobiyol Bul       Date:  2015-04       Impact factor: 0.622

3.  A previously undescribed coronavirus associated with respiratory disease in humans.

Authors:  Ron A M Fouchier; Nico G Hartwig; Theo M Bestebroer; Berend Niemeyer; Jan C de Jong; James H Simon; Albert D M E Osterhaus
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-08       Impact factor: 11.205

4.  Comparative evaluation of six commercialized multiplex PCR kits for the diagnosis of respiratory infections.

Authors:  Sylvie Pillet; Marina Lardeux; Julia Dina; Florence Grattard; Paul Verhoeven; Jérôme Le Goff; Astrid Vabret; Bruno Pozzetto
Journal:  PLoS One       Date:  2013-08-23       Impact factor: 3.240

5.  Epidemiology characteristics of respiratory viruses found in children and adults with respiratory tract infections in southern China.

Authors:  Dingmei Zhang; Zhenjian He; Lin Xu; Xun Zhu; Jueheng Wu; Weitao Wen; Yun Zheng; Yu Deng; Jieling Chen; Yiwen Hu; Mengfeng Li; Kaiyuan Cao
Journal:  Int J Infect Dis       Date:  2014-06-11       Impact factor: 3.623

6.  Newly identified respiratory viruses associated with acute lower respiratory tract infections in children in Lanzou, China, from 2006 to 2009.

Authors:  Y Jin; R-F Zhang; Z-P Xie; K-L Yan; H-C Gao; J-R Song; X-H Yuan; W-X Cheng; Y-D Hou; Z-J Duan
Journal:  Clin Microbiol Infect       Date:  2011-07-18       Impact factor: 8.067

7.  Comparison of two commercial molecular assays for simultaneous detection of respiratory viruses in clinical samples using two automatic electrophoresis detection systems.

Authors:  L E S Bruijnesteijn van Coppenraet; C M A Swanink; A A van Zwet; R H T Nijhuis; J Schirm; J A Wallinga; G J H M Ruijs
Journal:  J Virol Methods       Date:  2010-08-05       Impact factor: 2.014

8.  Evaluation of Anyplex™ II RV16 and RB5 real-time RT-PCR compared to Seeplex® RV15 OneStep ACE and PneumoBacter ACE for the simultaneous detection of upper respiratory pathogens.

Authors:  Gretchen Parrott; Takeshi Kinjo; Daijiro Nabeya; Ayako Uehara; Saifun Nahar; Kazuya Miyagi; Shusaku Haranaga; Masao Tateyama; Jiro Fujita
Journal:  J Infect Chemother       Date:  2017-08-19       Impact factor: 2.211

9.  Detection of pathogens by real-time PCR in adult patients with acute exacerbation of bronchial asthma.

Authors:  Yutaka Yoshii; Kenichiro Shimizu; Miyuki Morozumi; Naoko Chiba; Kimiko Ubukata; Hironori Uruga; Shigeo Hanada; Hiroshi Wakui; Shunsuke Minagawa; Hiromichi Hara; Takanori Numata; Keisuke Saito; Jun Araya; Katsutoshi Nakayama; Kazuma Kishi; Kazuyoshi Kuwano
Journal:  BMC Pulm Med       Date:  2017-11-22       Impact factor: 3.317

10.  Detection of six common human paramyxoviruses in patients with acute febrile respiratory symptoms using a novel multiplex real-time RT-PCR assay.

Authors:  Gao-Shan Liu; Pei-Hua Niu; Sheng-Cang Zhao; Rou-Jian Lu; Wen-Jie Tan
Journal:  J Med Virol       Date:  2018-11-19       Impact factor: 2.327

View more
  5 in total

1.  Rapid review protocol: Zinc for the prevention or treatment of COVID-19 and other coronavirus-related respiratory tract infections.

Authors:  Jennifer Hunter; Susan Arentz; Joshua Goldenberg; Guoyan Yang; Jennifer Beardsley; Dominik Mertz; Stephen Leeder
Journal:  Integr Med Res       Date:  2020-06-23

2.  Three Novel Real-Time RT-PCR Assays for Detection of COVID-19 Virus.

Authors:  Peihua Niu; Roujian Lu; Li Zhao; Huijuan Wang; Baoying Huang; Fei Ye; Wenling Wang; Wenjie Tan
Journal:  China CDC Wkly       Date:  2020-06-19

3.  Repurposing therapeutics for COVID-19: Rapid prediction of commercially available drugs through machine learning and docking.

Authors:  Sovesh Mohapatra; Prathul Nath; Manisha Chatterjee; Neeladrisingha Das; Deepjyoti Kalita; Partha Roy; Soumitra Satapathi
Journal:  PLoS One       Date:  2020-11-12       Impact factor: 3.240

4.  Epidemiological and clinical characteristics of respiratory viruses in 4403 pediatric patients from multiple hospitals in Guangdong, China.

Authors:  Yajie Zhang; Lin Qiao; Jinxiu Yao; Nan Yu; Xiaoping Mu; Shengqi Huang; Bo Hu; Weixuan Li; Feng Qiu; Fangyin Zeng; Cong Chen; Yuqiu Zhou; Bashan Zhang; Tian Cai; Weijia Wang; Xianjin Wu; Yiwen Zhou; Guochang Wang; Bo Situ; Shuling Lan; Na Li; Xiu Li; Zihua Li; Xin Li; Congrong Wang; Chao Yang; Pingfeng Feng; Hongxia Wang; Sijing Zhu; Yufeng Xiong; Min Luo; Wenjuan Shen; Xiumei Hu; Lei Zheng
Journal:  BMC Pediatr       Date:  2021-06-17       Impact factor: 2.125

5.  A Novel Coronavirus from Patients with Pneumonia in China, 2019.

Authors:  Na Zhu; Dingyu Zhang; Wenling Wang; Xingwang Li; Bo Yang; Jingdong Song; Xiang Zhao; Baoying Huang; Weifeng Shi; Roujian Lu; Peihua Niu; Faxian Zhan; Xuejun Ma; Dayan Wang; Wenbo Xu; Guizhen Wu; George F Gao; Wenjie Tan
Journal:  N Engl J Med       Date:  2020-01-24       Impact factor: 91.245

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.